/ Medtronic
Medtronic (MDT) Reports Strong Q4 Performance, Will Separate Diabetes Business
Medtronic's fourth-quarter performance exceeded expectations, with notable growth in key segments.
May 21, 2025Earnings Review: Medtronic Beats Expectations with 6% Increase in Revenue
Medtronic reported an EPS of $1.2, beating the expected $1.18. The firm's revenue grew by 6% in Q2 FY24.
November 21, 2023